Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Duchenne muscular dystrophy (DMD) nonprofit CureDuchenne is looking to spark public action through a new national public service announcement (PSA) campaign shining a light on what birthdays look l | CureDuchenne's "A Cure Can't Wait" serves as a public service announcement reminding viewers that "the clock is ticking" for patients and families with the rare progressive disease Duchenne muscular dystrophy.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

The case for direct-to-patient (DTP) has been clearly made. | The case for DTP is made. What separates programs that deliver from…

CureDuchenne Appoints Lidia Gardner, PhD, EMBA, as Vice President of Clinical and Medical Affairs to Advance Patient-Centered…

Dermatology drugmaker Leo Pharma and the scattering of patients across the globe with rare skin disease generalized pustular…

Explore how AI, advanced analytics and real-world data can help identify rare disease patients earlier, reduce diagnostic delays…

Early-onset cancers are rising among adults 18–49, reshaping how patients are diagnosed, supported, and engaged. This report…

Pharma companies need to strengthen and modernize patient support programs to reflect rising rates of cancer in adults aged 18 to…